Abstract
The goal of this study was to characterize growth, mineralization and bone formation of osteoblast-like cells in titanium pore channels of defined diameter. Titanium implants with continuous drill channels of diameters of 300, 400, 500, 600 and 1,000 µm were inserted into human osteoblast-like cell cultures. The ingrowth of the cells into the drill channels was investigated by transmitted-light microscopy and scanning electron microscopy. Immunofluorescence and histological analysis of 15-channel sections of each diameter were used to investigate the growth behavior and the matrix protein patterns. Mineralization was evidenced by Alizarin red staining and high-resolution microradiography. The ingrowth of human osteoblast-like cells in the drill channels occurred in a sequence of four characteristic stages. In stage 1, osteoblast precursor cells adhered to the wall of the channel and migrated three-dimensionally into the channel by forming foot-like protoplasmic processes. For all 15 sample drill channels that were investigated, the cell ingrowth over 20 days amounted on average to 793 µm (± 179) into 600-µm-diameter channels, where they migrated significantly faster than in all the other channels. In stage 2, approximately on day 5–7, the osteoblast-like cells began to anchor on the substrate wall by matrix proteins and to build up a dense network of matrix proteins in the drill channel. The mineralization of the extracellular matrix, while depending on cell stimulation, was initiated in stage 3, on average after 4 weeks. In drill channels of a diameter of 1,000 µm the cell growth was incomplete and no mineralization was found by radiological assessment. Starting in week 6, in the drill channels of diameters ranging from 300 to 600 µm, the network of extracellular matrix proteins and osteoblast-like cells began to form an osteon-like structure. Neither the highly developed migration behavior of osteoblastic cells nor the reorganization from a fiber-like matrix to a lamellar structure have so far been described for cell cultures.
References
1.
Basle, M.F., M. Lesourd, F. Grizon, C. Pascaretti, D. Chappard (1998) Type I collagen in xenogenic bone material regulates attachment and spreading of osteoblasts over the beta1 integrin subunit. Orthopäde 27: 136–142.
2.
Batzer, R., Y. Liu, D.L. Cochran, S. Szmuckler-Moncler, D. Dean, B.D. Boyan, Z. Schwartz (1998) Prostaglandins mediate the effects of titanium surface roughness on MG63 osteoblast-like cells and alter cell responsiveness to 1α,25-(OH)2D3. J Biomed Mater Res 41: 489–496.
3.
Beresford, J.N., J.A. Gallagher, J.W. Poser, R.G.G. Russell (1984) Production of osteocalcin by human bone cells in vitro. Effects of 1,25-(OH)2D3, 24,25-(OH)2D3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Relat Res 5: 229–234.
4.
Black, J. (1992) Biological Performance of Materials. New York, Marcel Dekker.
5.
Boyan, B.D., T.W. Hummert, D.D. Dean, Z. Schwartz (1996) Role of material surfaces in regulating bone and cartilage cell response. Biomaterials 17: 137–146.
6.
Brunette, D.M., B. Chehroudi (1999) The effects of the surface topography of micromachined titanium substrata on cell behavior in vitro and in vivo. J Biomech Eng 121: 49–57.
7.
Burger, E.H., J. Klein-Nulend (1999) Mechanotransduction in bone – Role of the lacuno-canalicular network. FASEB J 13: 101–112.
8.
Buser, D., R.K. Schenk, S. Steinemann, J.P. Fiorellini, C.H. Fox, H. Stich (1991) Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. J Biomed Mater Res 25: 889–902.
9.
Cameron, H.U., R.M. Pilliar, I. Macnab (1976) The rate of bone ingrowth into porous metal. J Biomed Mater Res 7: 301.
10.
Carter, D.R., W.C. Hayes (1977) Compact bone fatigue damage: A microscopic examination. Clin Orthop 127: 265–274.
11.
Davies, J.E. (1996) In vitro modeling of the bone/implant interface. Anat Rec 245: 426–445.
12.
Dresing, K. (1999) Knochenwachstum in definierte Porenkanäle im Tierversuch, Habilitationsschrift, Göttingen, pp 130–134.
13.
Edwards, J.T., J.B. Brunski, H.W. Higuchi (1997) Mechanical and morphologic investigation of the tensile strength of a bone-hydroxyapatite interface. J Biomed Mater Res 36: 454–468.
14.
Frosch K.-H., C.H. Lohmann, F. Barvencik, V. Viereck, J. Breme, K.M. Stuermer (2000) Licht- und elektronenmikroskopische Charakteristika humaner Osteoblasten im dreidimensionalen Kulturmodell von Titan-, Aluminiumoxid- und Zirkoniumoxid-Implantaten. Osteologie 9 (suppl 1): 16.
15.
Geissler, U., U. Hempel, C. Wolf, D. Scharnweber, H. Worch, K. Wenzel (2000) Collagen type I-coating of Ti6Al4V promotes adhesion of osteoblasts. J Biomed Mater Res 51: 752–760.
16.
Glantz, P.O. (1998) The choice of alloplastic materials for oral implants: Does it really matter? Int J Prosthodont 11: 402–407.
17.
Gray, C. (1998) Advanced bone formation in grooves in vitro is not restricted to calcified biological materials. Tissue Eng 4: 315–323.
18.
Gronowitz, G., M.B. McCarthy (1996) Response of human osteoblasts to implant materials: Integrin-mediated adhesion. J Orthop Res 14: 878–887.
19.
Hong, L., H.C. Xu, K. de Groot (1992) Tensile strength of the interface between hydroxyapatite and bone. J Biomed Mater Res 26: 7–18.
20.
Howlett, C.R., M.D.M. Evans, W.R. Walsh, G. Johnson, J.G. Steel (1994) Mechanism of initial attachment of cells derived from human bone to commonly used prosthetic materials during cell culture. Biomaterials 15: 213–222.
21.
Huiskes, R., R. Ruimerman, G.H. van Lenthe, J.D. Janssen (2000) Effects of mechanical forces on maintenance and adaptation of form in trabecular bone. Nature 405: 704–706.
22.
Hulbert, S.F., F.A. Young, R.S. Mathews, J.J. Klawitter, C.D. Talbert, F.H. Stelling (1970) Potential of ceramic materials as permanently implantable skeletal prothesis. J Biomed Mater Res 4: 433.
23.
Karbe, E., K. Köster, H. Kramer, H. Heide, G. Kling, R. König (1975) Bone growth in porous ceramic implants in dogs. Langenbecks Arch Chir 338: 109–116.
24.
Kasemo, B., J. Gold (1999) Implant surfaces and interface processes. Adv Dent Res 13: 8–20.
25.
Klawitter, J.J., A.M. Weinstein, S.F. Hulbert, B.W. Sauer (1976) Tissue ingrowth and mechanical locking for anchorage of prostheses in locomotor system; in Schaldach, M., D. Hohmann (eds): Advances in Artificial Hip and Knee Joint Technology. Springer, Berlin, p 422.
26.
Koontz, C.S., W.K. Ramp, R.D. Peindl, K.K. Kaysinger, M.E. Harrow (1998) Comparison of growth and metabolism of avian osteoblasts on polished disks versus thin films of titanium alloy. J Biomed Mater Res 42: 238–244.
27.
Kurachi, T., H. Nagao, H. Nagura, S. Enomoto (1997) Effect of a titanium surface on bone marrow-derived osteoblastic cells in vitro. Arch Oral Biol 42: 465–468.
28.
Lausmaa, J., B. Kasemo, U. Rolander, L.M. Bjursten, L.E. Ericson, L. Rosander, P. Thomsen (1988) Preparation, surface spectroscopic and electron microscopic characterisation of titanium implant materials; in Ratner, B.D. (ed): Surface Characterization of Biomaterials. Amsterdam, Elsevier, pp 161–174.
29.
Lincks, J., B.D. Boyan, C.R. Blanchard, C.H. Lohmann, Y. Liu, D.L. Cochran, D.D. Dean, Z. Schwartz (1998) Response of MG63 osteoblast-like cells to titanium and titanium alloy is dependent on surface roughness and composition. Biomaterials 19: 2219–2232.
30.
Marie, P., F. Debiais, M. Cohen-Solal, M.C. de Vernejoul (2000) New factors controlling bone remodeling. Joint Bone Spine 67: 150–156.
31.
Masuda, T., G.E. Salvi, S. Offenbacher, D.A. Felton, L.F. Cooper (1997) Cell and matrix reactions at titanium implants in surgically prepared rat tibiae. Int J Oral Maxillofac Implants 12: 472–485.
32.
Moskalewski, S., P.M. Boonekamp, J.P. Scherft (1983) Bone formation by isolated calvarial osteoblasts in syngeneic and alogeneic transplants: Light microscopic observations. Am J Anat 167: 249–263.
33.
Neo, M., C.F. Voigt, H. Herbst, U.M. Gross (1998) Osteoblast reaction at the interface between surface-active materials and bone in vivo: A study using in situ hybridisation. J Biomed Mater Res 39: 1–8.
34.
Owen, T.A., M. Aronow, V. Shalhub, L.M. Barone, L. Wilming, M.S. Tassinari, M.B. Kennedy, S. Pockwinse, J.B. Lian, G.S. Stein (1990) Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of bone extracellular matrix. J Cell Physiol 143: 420–430.
35.
Piattelli, A., L. Manzon, A. Scarano, M. Paolantonio, M. Piattelli (1998) Histologic and histomorphometric analysis of the bone response to machined and sandblasted titanium implants: An experimental study in rabbits. Int J Oral Maxillofac Implants 13: 805–810.
36.
Predecki, P., J.E. Stephan, B.A. Auslaender (1972) Kinetics of bone growth into cylindrical channels in aluminium oxide and titanium. J Biomed Mater Res 6: 375–400.
37.
Puelo, D.A., A. Nanci (1999) Understanding and controlling the bone-implant interface. Biomaterials 20: 2311–2321.
38.
Roehlecke, C., M. Witt, M. Kasper, E. Schulze, C. Wolf, A. Hofer, R.H.W. Funk (2001) Synergistic effect of titanium alloy and collagen type I on cell adhesion, proliferation and differentiation of osteoblast-like cells. Cells Tissues Organs 168: 178–187.
39.
Singer, I., S. Scott, D.W. Kawaka, D.M. Kazazis, J. Gailit, E. Ruoslahti (1988) Cell surface distribution of fibronectin and vitronectin receptor depends on substrate composition and extracellular matrix accumulation. J Cell Biol 106:2171–2182.
40.
Sinha, R.K., F. Morris, S.A. Shah, R.S. Tuan (1994) Surface composition of orthopaedic implant metals regulates cell attachment, spreading, and cytoskeletal organization of primary human osteoblasts in vitro. Clin Orthop 305:258–272.
41.
Sinha, R.K., R.S. Tuan (1996) Regulation of human osteoblast integrin expression by orthopedic implant materials. Bone 18: 451–457.
42.
Stuermer, K.M. (1980) Mikroradiographie des Knochens, Technik, Aussagekraft und Planimetrie. Hefte Unfallheilk 148: 247–251.
43.
Sundgren, J.-E., P. Bodo, I. Lundstrom (1986) Auger electron spectroscopic studies of the interface between human tissue and implants of titanium and stainless steel. J Colloid Interface Sci 110: 9–20.
44.
Sundgren, J.E., P. Bodo, I. Lundstrom, A. Berggren, S. Hellem (1985) Auger electron spectroscopic studies of stainless-steel implants. J Biomed Mater Res 19: 663–671.
45.
Takayuki, M., G.E. Salvi, S. Offenbacher, D.A. Felton, L.F. Cooper (1997) Cell and matrix reactions at titanium implants in surgically prepared rat tibiae. Int J Maxillofac Implants 12:472–485.
46.
Tanaka-Kamioka, K., H. Kamioka, H. Ris, S.S. Lim (1998) Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections. J Bone Miner Res 13: 1555–1568.
47.
Thomas, K.A., S.D. Cook (1985) An evaluation of variables influencing implant fixation by direct bone apposition. J Biomed Mater Res 19: 875–901.
48.
Wong, M., J. Eulenberger, R. Schenk, E. Hunziker (1995) Effect of surface topology on the osseointegration of implant materials in trabecular bone. J Biomed Mater Res 29: 1567–1575.
49.
Zeng, Y., S.C. Cowin, S. Weinbaum (1994) A fiber matrix model for fluid flow and streaming potentials in the canaliculi of an osteon. Ann Biomed 22: 280–292.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
